NCT03444883 - Phase III Study to Evaluate Safety and Efficacy of Ilaprazole in Patients With NERD | Biotech Hunter

Enrollment

277

Participants

Timeline

Start Date

October 31, 2018

Primary Completion Date

February 25, 2020

Study Completion Date

February 25, 2020

Conditions

Non-erosive Reflux Disease

Interventions

DRUG

Ilaprazole

10mgx2 tablet once daily for weeks

Trial Locations (11)

Seoul National University Bundang Hospital, Seongnam-si

Inje University Busan Paik Hospital, Busan

Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul

Chonbuk National University Hospital, Jeonju

Kangbuk Samsung Hospital, Sungkyunkwan University, Seoul

Seoul National University Hospital, Seoul

Inje University Seoul Paik Hospital, Seoul

Severance Hospital Yonsei University Health System, Seoul

Asan Medical Center, Seoul

Soon Chun Hyang University Hospital, Buchon, Bucheon-si

Ewha Womans University Mokdong Hospital, Seoul

All Listed Sponsors

lead

Il-Yang Pharm. Co., Ltd.

INDUSTRY